ANL Adlai Nortye Group Ltd.
$15.21▲ +0.80%
Healthcare
Other
After hours
$15.13▼ -0.53%
Sep 11, 7:30 PM ET
Volume 228.7K
Avg Volume (10D) 189.4K
Key Metrics & Fundamentals
Market Cap
$979.49M
P/E Ratio
–
Div Yield
–%
52W Range
0.88 - 17.25
% vs 50 MA
17.97%
% vs 200 MA
64.05%
RSI-14
60.0
MACD Histogram
+0.0400
Beta (1Y vs SPY)
1.87
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
GlobeNewswire · Sep 8, 2026 11:00 AM
These 2 ‘Monster Growth’ Stocks Aren’t Done Climbing, Say Analysts
TipRanks · Sep 6, 2026 6:00 PM
Wall Street Analysts See an 81.78% Upside in Adlai Nortye Ltd. Sponsored ADR (ANL): Can the Stock Really Move This High?
Zacks · Aug 18, 2026 1:55 PM
Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress
GlobeNewswire · Aug 14, 2026 11:00 AM
Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia
GlobeNewswire · Aug 3, 2026 11:00 AM
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025
GlobeNewswire · Jul 16, 2026 11:00 AM
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
GlobeNewswire · Jul 13, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Avg +0.50 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.